With a median follow-up period of 67 months, the ALDH1 expression was significantly correlated with metastasis-free survival (MFS; P=0.01) as well as with tumor-specific survival (SS; P=0.03) [40]. The gene discussed is ALDH1A1; the disease is neoplasm.